Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Capital Leases (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Capital Leases for 2 consecutive years, with $23000.0 as the latest value for Q4 2025.

  • Quarterly Capital Leases fell 77.0% to $23000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23000.0 through Dec 2025, down 77.0% year-over-year, with the annual reading at $23000.0 for FY2025, 77.0% down from the prior year.
  • Capital Leases for Q4 2025 was $23000.0 at Pyxis Oncology, down from $43000.0 in the prior quarter.
  • The five-year high for Capital Leases was $135000.0 in Q2 2024, with the low at $23000.0 in Q4 2025.